Speculation is building that President Donald Trump may delay the introduction of his 100% tariff rate on pharmaceutical ...

The Construction Industry Institute reports that rework can swallow up to 20% of construction costs. In pharma, where GMP ...

The AI Structural Biology (AISB) consortium was set up earlier this year to fine-tune OpenFold3, which is being developed by ...

As the third quarter of 2025 draws to a close, the clinical research landscape has been marked by a surge of promising data, ...

As academic researchers experience a worsening funding crunch and pharma companies are increasingly hungry for large, ...

Purposeful prescribing is the idea of making thoughtful, patient-centred decisions about medication – choices that reflect not only the diagnosis, but also what the patient is going through, what ...

“About a third of women affected by a UTI will go on to have recurrent UTIs. This can happen for several reasons, for ...

The results of a phase 3 trial of Vertanical's cannabis-derived therapy VER-01 for chronic lower back pain have been ...

Crystalys Therapeutics has emerged from its cocoon with $205 million first-round financing and a potential treatment for gout ...

In another episode of our limited Frontiers Health series of the pharmaphorum podcast, we speak with commercial strategy ...

Walmsley will step down from the board of directors of GSK at the end of the year, and will step down as CEO on 30th ...

Pfizer has also agreed to invest $70 billion to bring manufacturing to the United States in exchange for relief from the ...